DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Chatillon, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
109
Frequently Asked Questions
What is Market Cap of DBV Technologies?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. DBV Technologies market cap is $266.64M.
What is the 52-week high for DBV Technologies?
52 week high is the highest price of a stock in the past 52 weeks, or one year. DBV Technologies 52 week high is $1.95 as of September 05, 2025.
What is the 52-week low for DBV Technologies?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. DBV Technologies 52 week low is $0.0001 as of September 05, 2025.
What is DBV Technologies stock price today?
DBV Technologies stock price today is $1.95.
What was DBV Technologies stock price yesterday?
DBV Technologies stock price yesterday was $0.0001.
What is the PE ratio of DBV Technologies?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. DBV Technologies’s P/E ratio is -1.74.
What is the Price-to-Book ratio of DBV Technologies?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. DBV Technologies P/B ratio is 3.0930.
What is the 50-day moving average of DBV Technologies?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. DBV Technologies 50-day moving average is $1.54.
